• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Cancer Vaccine Market, Global Research Reports 2020-2021

report cover
  • 20 May 2020
  • Healthcare
  • 92 Pages
  • Report Code: 24LS-2846
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Cancer Vaccine Market Reports -MARKET ADVISORY SERVICES

This report covers market size and forecasts of Cancer Vaccine, including the following market information:
Global Cancer Vaccine Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Cancer Vaccine Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Cancer Vaccine Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Cancer Vaccine Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)

Key market players
Major competitors identified in this market include Dendreon Corporation, NeoStem Oncology, ImmunoGen, Inovio Pharmaceuticals, Novartis, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Preventive vaccines
Therapeutic vaccines

Based on the Application:
Prostate Cancer
Cervical Cancer
Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Cancer Vaccine Industry
1.7 COVID-19 Impact: Cancer Vaccine Market Trends

2 Global Cancer Vaccine Quarterly Market Size Analysis
2.1 Cancer Vaccine Business Impact Assessment - COVID-19
2.1.1 Global Cancer Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Cancer Vaccine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Cancer Vaccine Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020
3.1 Global Cancer Vaccine Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Cancer Vaccine Factory Price by Manufacturers
3.3 Location of Key Manufacturers Cancer Vaccine Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Cancer Vaccine Market
3.5 Key Manufacturers Cancer Vaccine Product Offered
3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Cancer Vaccine Segments, By Type
4.1 Introduction
1.4.1 Preventive vaccines
1.4.2 Therapeutic vaccines
4.2 By Type, Global Cancer Vaccine Market Size, 2019-2021
4.2.1 By Type, Global Cancer Vaccine Market Size by Type, 2020-2021
4.2.2 By Type, Global Cancer Vaccine Price, 2020-2021

5 Impact of Covid-19 on Cancer Vaccine Segments, By Application
5.1 Overview
5.5.1 Prostate Cancer
5.5.2 Cervical Cancer
5.5.3 Others
5.2 By Application, Global Cancer Vaccine Market Size, 2019-2021
5.2.1 By Application, Global Cancer Vaccine Market Size by Application, 2019-2021
5.2.2 By Application, Global Cancer Vaccine Price, 2020-2021

6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa

7 Company Profiles
7.1 Dendreon Corporation
7.1.1 Dendreon Corporation Business Overview
7.1.2 Dendreon Corporation Cancer Vaccine Quarterly Production and Revenue, 2020
7.1.3 Dendreon Corporation Cancer Vaccine Product Introduction
7.1.4 Dendreon Corporation Response to COVID-19 and Related Developments
7.2 NeoStem Oncology
7.2.1 NeoStem Oncology Business Overview
7.2.2 NeoStem Oncology Cancer Vaccine Quarterly Production and Revenue, 2020
7.2.3 NeoStem Oncology Cancer Vaccine Product Introduction
7.2.4 NeoStem Oncology Response to COVID-19 and Related Developments
7.3 ImmunoGen
7.3.1 ImmunoGen Business Overview
7.3.2 ImmunoGen Cancer Vaccine Quarterly Production and Revenue, 2020
7.3.3 ImmunoGen Cancer Vaccine Product Introduction
7.3.4 ImmunoGen Response to COVID-19 and Related Developments
7.4 Inovio Pharmaceuticals
7.4.1 Inovio Pharmaceuticals Business Overview
7.4.2 Inovio Pharmaceuticals Cancer Vaccine Quarterly Production and Revenue, 2020
7.4.3 Inovio Pharmaceuticals Cancer Vaccine Product Introduction
7.4.4 Inovio Pharmaceuticals Response to COVID-19 and Related Developments
7.5 Novartis
7.5.1 Novartis Business Overview
7.5.2 Novartis Cancer Vaccine Quarterly Production and Revenue, 2020
7.5.3 Novartis Cancer Vaccine Product Introduction
7.5.4 Novartis Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis
8.1 Cancer Vaccine Supply Chain Analysis
8.1.1 Cancer Vaccine Supply Chain Analysis
8.1.2 Covid-19 Impact on Cancer Vaccine Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Cancer Vaccine Distribution Channels
8.2.2 Covid-19 Impact on Cancer Vaccine Distribution Channels
8.2.3 Cancer Vaccine Distributors
8.3 Cancer Vaccine Customers

9 Key Findings

10 Appendix
10.1 About Us
10.2 Disclaimer
List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Cancer Vaccine Assessment

Table 9. COVID-19 Impact: Cancer Vaccine Market Trends

Table 10. COVID-19 Impact Global Cancer Vaccine Market Size

Table 11. Global Cancer Vaccine Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (MT)

Table 12. Global Cancer Vaccine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)

Table 13. Global Cancer Vaccine Quarterly Market Size, 2020 (US$ Million) & (MT)

Table 14. Global Cancer Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Cancer Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (MT)

Table 16. Global Cancer Vaccine Market Growth Drivers

Table 17. Global Cancer Vaccine Market Restraints

Table 18. Global Cancer Vaccine Market Opportunities

Table 19. Global Cancer Vaccine Market Challenges

Table 20. Key Manufacturers Cancer Vaccine Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Cancer Vaccine Market Size, 2019 (MT) & (US$ Million)

Table 22. Cancer Vaccine Factory Price by Manufacturers 2020 (USD/MT)

Table 23. Location of Key Manufacturers Cancer Vaccine Manufacturing Plants

Table 24. Key Manufacturers Cancer Vaccine Market Served

Table 25. Date of Key Manufacturers Enter into Cancer Vaccine Market

Table 26. Key Manufacturers Cancer Vaccine Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Cancer Vaccine Market Size by Type, 2020, (US$ Million)

Table 29. Global Cancer Vaccine Market Size by Type, 2020 (MT)

Table 30. Global Cancer Vaccine Price: by Type, 2020-2021 (USD/MT)

Table 31. Global Cancer Vaccine Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Cancer Vaccine Market Size by Application, 2020-2021 (MT)

Table 33. Global Cancer Vaccine Price: by Application, 2020-2021 (USD/MT)

Table 34. Global Cancer Vaccine Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Cancer Vaccine Market Size by Region, 2019-2021 (MT)

Table 36. By Country, North America Cancer Vaccine Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Cancer Vaccine Market Size, 2019-2021 (MT)

Table 38. US Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 39. Canada Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Cancer Vaccine Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Cancer Vaccine Market Size, 2019-2021 (MT)

Table 43. Germany Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 44. France Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 45. UK Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 46. Italy Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Cancer Vaccine Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Cancer Vaccine Market Size, 2019-2021 (MT)

Table 50. China Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 51. Japan Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 52. South Korea Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 53. India Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 54. ASEAN Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 55. Latin America Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 56. Middle East and Africa Cancer Vaccine Market Size, 2019-2021 (US$ Million) & (MT)

Table 57. Dendreon Corporation Business Overview

Table 58. Dendreon Corporation Cancer Vaccine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Dendreon Corporation Cancer Vaccine Product

Table 60. Dendreon Corporation Response to COVID-19 and Related Developments

Table 61. NeoStem Oncology Business Overview

Table 62. NeoStem Oncology Cancer Vaccine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. NeoStem Oncology Cancer Vaccine Product

Table 64. NeoStem Oncology Response to COVID-19 and Related Developments

Table 65. ImmunoGen Business Overview

Table 66. ImmunoGen Cancer Vaccine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. ImmunoGen Cancer Vaccine Product

Table 68. ImmunoGen Response to COVID-19 and Related Developments

Table 69. Inovio Pharmaceuticals Business Overview

Table 70. Inovio Pharmaceuticals Cancer Vaccine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Inovio Pharmaceuticals Cancer Vaccine Product

Table 72. Inovio Pharmaceuticals Response to COVID-19 and Related Developments

Table 73. Novartis Business Overview

Table 74. Novartis Cancer Vaccine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Novartis Cancer Vaccine Product

Table 76. Novartis Response to COVID-19 and Related Developments

Table 77. Cancer Vaccine Distributors List

Table 78. Cancer Vaccine Customers List

Table 79. Covid-19 Impact on Cancer Vaccine Customers

List of Figures

Figure 1. Cancer Vaccine Product Picture

Figure 2. Cancer Vaccine Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Cancer Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Cancer Vaccine Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Cancer Vaccine Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Cancer Vaccine Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Cancer Vaccine Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Cancer Vaccine Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Cancer Vaccine Market Size Market Share, 2019-2021

Dendreon Corporation

NeoStem Oncology

ImmunoGen

Inovio Pharmaceuticals

Novartis

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2763

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase